RxDoctor Payments Data

Nan Ambrosy

Psychiatric/Mental Health · Des Moines, IANPI 1144325648

Payments from drug & device makers

$2,709in general payments, 2019–2025

Across 141 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$575
  • Johnson & Johnson$459
  • Alkermes, Inc.$420
  • Otsuka America Pharmaceutical, Inc.$274
  • Teva Pharmaceuticals USA, Inc.$166
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$129
  • plus $686 from 12 others

What the payments were for

  • Food & beverage$2,709100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,709 in reported general payments places this provider in the 75th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$28,123
Medicare patients
113
Services billed
404

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate24$185,637
VraylarCariprazine Hcl63$90,332
TrintellixVortioxetine Hydrobromide25$31,871
Paliperidone ErPaliperidone46$12,045
FanaptIloperidone11$11,844
Lurasidone Hcl46$9,012
NamzaricMemantine Hcl/Donepezil Hcl14$8,094
Asenapine Maleate12$6,790
Bupropion XlBupropion Hcl206$5,474
Venlafaxine Hcl ErVenlafaxine Hcl158$5,402
CymbaltaDuloxetine Hcl12$4,519
Ziprasidone Hcl46$3,819
Quetiapine Fumarate170$3,805
Aripiprazole128$3,634
Oxcarbazepine77$3,516

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$114$185,63724 claims
AbbVieVraylar, Namzaric$575$98,42777 claims
Vanda Pharmaceuticals Inc.Fanapt$19$11,84411 claims
Almatica Pharma LLCSertraline Hcl$46$742112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →